Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime

[1]  Michael Hoelscher,et al.  Assessment of the novel T-cell activation marker-tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study. , 2014, The Lancet. Infectious diseases.

[2]  J. Novak,et al.  Differential glycosylation of envelope gp120 is associated with differential recognition of HIV-1 by virus-specific antibodies and cell infection , 2014, AIDS Research and Therapy.

[3]  T. Hanke.  Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines , 2014, Expert opinion on biological therapy.

[4]  S. Chakraborty,et al.  Characterization of the Protective HIV-1 CTL Epitopes and the Corresponding HLA Class I Alleles: A Step towards Designing CTL Based HIV-1 Vaccine , 2014, Advances in virology.

[5]  Kristof Theys,et al.  Functional conservation of HIV-1 Gag: implications for rational drug design , 2013, Retrovirology.

[6]  T. Hertz,et al.  HIV-1 Vaccine-Induced T-Cell Reponses Cluster in Epitope Hotspots that Differ from Those Induced in Natural Infection with HIV-1 , 2013, PLoS pathogens.

[7]  M. Carrington,et al.  Association of HLA-DRB1-restricted CD4+ T cell responses with HIV immune control , 2013, Nature Medicine.

[8]  J. Nie,et al.  A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization , 2013, Retrovirology.

[9]  B. Walker,et al.  HIV and HLA class I: an evolving relationship. , 2012, Immunity.

[10]  D. Heckerman,et al.  HIV-Specific CD4 T Cell Responses to Different Viral Proteins Have Discordant Associations with Viral Load and Clinical Outcome , 2011, Journal of Virology.

[11]  Mario Roederer,et al.  SPICE: Exploration and analysis of post‐cytometric complex multivariate datasets , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[12]  M. Hoelscher,et al.  A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172). , 2010, The Journal of infectious diseases.

[13]  B. Korber,et al.  HIV-1 vaccine development after STEP. , 2010, Annual review of medicine.

[14]  P. Earl,et al.  Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines. , 2009, Vaccine.

[15]  R. Koup,et al.  Minor viral and host genetic polymorphisms can dramatically impact the biologic outcome of an epitope-specific CD8 T-cell response. , 2009, Blood.

[16]  D. Montefiori,et al.  Immune Control of an SIV Challenge by a T Cell-Based Vaccine in Rhesus Monkeys , 2008, Nature.

[17]  David Heckerman,et al.  Broad and Gag-Biased HIV-1 Epitope Repertoires Are Associated with Lower Viral Loads , 2008, PloS one.

[18]  E. Rosenberg,et al.  Recognition of a Defined Region within p24 Gag by CD8+ T Cells during Primary Human Immunodeficiency Virus Type 1 Infection in Individuals Expressing Protective HLA Class I Alleles , 2007, Journal of Virology.

[19]  C. Gray,et al.  In a mixed subtype epidemic, the HIV-1 Gag-specific T-cell response is biased towards the infecting subtype , 2007, AIDS.

[20]  R. Koup,et al.  Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation , 2006, The Journal of experimental medicine.

[21]  E. Rosenberg,et al.  Comprehensive Analysis of Human Immunodeficiency Virus Type 1-Specific CD4 Responses Reveals Marked Immunodominance of gag and nef and the Presence of Broadly Recognized Peptides , 2004, Journal of Virology.

[22]  M. Altfeld,et al.  Impact of intrapeptide epitope location on CD8 T cell recognition: implications for design of overlapping peptide panels , 2004, AIDS.

[23]  D. Strick,et al.  Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load , 2003, Journal of Virology.

[24]  E. Rosenberg,et al.  Differential Narrow Focusing of Immunodominant Human Immunodeficiency Virus Gag-Specific Cytotoxic T-Lymphocyte Responses in Infected African and Caucasoid Adults and Children , 2000, Journal of Virology.

[25]  G. Shaw,et al.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.